Current reports
Current report 29/2021 – adoption of a resolution of the Company’s Management Board on amending the resolution on the share capital increase as part of its authorized capital
adoption of a resolution of the Company’s Management Board on amending the resolution on the share capital increase as part of its authorized capital
Current report 28/2021 – Signing of a letter of intent on commencing cooperation with Tarchomińskie Zakłady Farmaceutyczne S.A.
Signing of a letter of intent on commencing cooperation with Tarchomińskie Zakłady Farmaceutyczne S.A.
Current report 27/2021 – Status update of the phase II clinical trial on an esketamine-based drug in patients with bipolar depression
Status update of the phase II clinical trial on an esketamine-based drug in patients with bipolar depression
Current report No 26/2021 – submission of an application for consent to commence a phase II trial of CPL’280 in treatment of type 2 diabetes.
Submission of an application for consent to commence a phase II trial of CPL’280 in treatment of type 2 diabetes.
Current report 25/2021– Notice on convening the Ordinary General Meeting of Celon Pharma S.A. on June 29, 2021 with draft resolutions
Date prepared: 06/02/2021 Abbreviated name of the issuer: CELON PHARMA S.A. Subject: Notice on convening the Ordinary General Meeting of Celon Pharma S.A. on June 29, 2021 with draft resolutions Legal basis Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information Content of the report: Read more »
Current report 24/2021– The Management Board’s recommendation on the distribution of profit for the year 2020
The Management Board’s recommendation on the distribution of profit for the year 2020
Current report No. 23/2021 – changing dates for submitting periodical reports for the 1st quarter of 2021
Current reports May 17, 2021 Date prepared: May 17,2021 Legal basis Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information Content of the report: The Management Board of Celon Pharma S.A. informs that the date of releasing the periodical report for 1Q2021 to the public was changed.Read more »
Current report No. 22/2021 – Adoption of a resolution on the issue of shares as part of increasing the Company’s authorized share capital; repealing of the previous resolution
Current reports May 10, 2021 Legal basis Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information Content of the report: Management Board of Celon Pharma S.A. (“Company”) informs that on May 10, 2021 a resolution was adopted concerning the issue of not less than 1 and notRead more »
Current report 21/2021 – entering the authorized capital and the increase in the Company’s share capital into the National Court Register (KRS)
Current reports May 6, 2021 Management Board of Celon Pharma S.A. The “Company” informs that on May 5, 2021, it was entered into the register of the Regional Court for the capital city of Warsaw in Warsaw, 14th Economic Division of the National Court Register, entry in Section No. 8 of the KRS: Adoption ofRead more »